MDD Treatment Alternatives Explore Potential of Cannabis, Psychedelics
November 28th 2022Stemming from recent data on a potential link between major depressive disorder (MDD) and inflammation, research is starting to turn toward alternatives that can treat the disease through anti-inflammatory effects, including ketamine, cannabinoids, and psychedelics.
Read More
Study Details Pandemic’s Depressive Effects in Older Adults
November 25th 2022It is well-known that depression generally, as well as the demand for mental health care, surged because of the pandemic, but few studies have identified the percentage of individuals who experienced depression for the first time after the pandemic began, or the percentage of those with a history of depression who saw it return.
Read More
Study Finds Links Between Alcohol Consumption and Smoking in Adolescence and Later Mood Disorders
October 20th 2022While links between adolescent coffee habits in adolescents and mood disorders in adulthood were not seen, researchers did find evidence for later health issues related to smoking and alcohol.
Read More
Childhood Trauma Not a Barrier to Successful Depression Treatment, Analysis Finds
September 22nd 2022Prior research has suggested that childhood trauma is linked with a poorer response to psychotherapy and prescription drug treatment for major depressive disorder, but a large meta-analysis suggested otherwise.
Read More
HHS declared a public health emergency in Puerto Rico due to Hurricane Fiona; nearly 1 in 10 Americans suffered from depression in 2020, and a task force recommended doctors screen all adults aged younger than 65 for anxiety; advances in cancer research have led to reduced cancer death rates.
Read More
Which Depression Therapies Made the Updated US Guideline for Treating MDD?
September 19th 2022Newer therapies, such as ketamine or esketamine, or the broader use of bright light therapy, made an updated clinical practice guideline for treating major depressive disorder (MDD), but psilocybin and cannabis did not.
Read More
Recommendations to Increase Equitable Psychosocial Outcomes for Children and Adolescents
September 18th 2022Nearly 30% of youths are affected with worsening mental health by the end of adolescence, with anxiety typically presenting in childhood and depression during the teenage years, but the problem is even more acute for Black and Latinx youth.
Read More
More Diversity, Multifaceted Outreach Needed in Studies of Genetic Screening for Depression
September 15th 2022Three types of salient beliefs were investigated in this study that examined why mothers would or would not participate in depression screening via genetic salivary testing, with the results indicating potential for mental health disparities among diverse populations.
Read More
Experiencing Psychological Distress Before Infection Linked With Long COVID
September 8th 2022Feeling depressed, anxious, worried, stressed, or lonely was linked with a higher risk of developing long COVID and hurting the ability to function in daily life, according to a study published this week.
Read More
Depression Screening Shown to Benefit Persons Living With Breast Cancer
January 25th 2022This new study of data from Kaiser Permanente Southern California compared outcomes for behavioral health referrals among patients with breast cancer between those receiving a tailored intervention or an education-only approach.
Read More
Genetic Predisposition for Elevated BMI May Increase Risk of MS, Depression
March 12th 2021A causal relationship between major depressive disorder (MDD) and multiple sclerosis (MS), and vice versa, was not found in a recent Mendelian randomization study, while higher body mass index (BMI) was shown to increase the risk for both.
Read More